HIF1A and cancer: PKM2 enzyme acts as a coactivator of HIF-1α itself to stimulate chromatin binding, coactivator recruitment, and transcriptional activation [39], leading to a metabolic reprogramming of cancer cells and favoring other processes of cancer progression, such as angiogenesis.